Quick Answer
Mereo BioPharma Group plc reported Total Revenue of $500.0 thousand for the year ending 2025.
- This data is from Mereo BioPharma Group plc's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $0.00 | Q2 2023: $9.00 million | Q3 2023: $0.00 | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00 | Q2 2025: $500.0 thousand | Q3 2025: $0.00.
- Historical annual values: Fiscal year 2025: $500.0 thousand | Fiscal year 2024: $0.00 | Fiscal year 2023: $10.00 million | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: